BioAgilytix has appointed its new scientific officer for BioAgilytix Europe, Dr Lydia Michaut. Lydia brings a wealth of experience in immunology, genetics, gene therapy and regulated bioanalysis to the company, and is perfectly placed to liaise with clients to ensure that BioAgilytix delivers high quality laboratory services tailored to their specific needs.
Lydia obtained a PhD in molecular biology and innate immunity from Louis Pasteur University, Strasbourg, where she studied with Nobel Laureate Professor Jules Hoffmann, before taking up a postdoctoral position with the world-renowned developmental biologist Professor Walter Gehring at Biozentrum, University of Basel. After 15 years in academia, she moved to Swiss pharma company Novartis, where she became one of the first members of staff dedicated to the scientific interface between the company and bioanalytical contract research organisations.
“I have been fortunate to work with some very high caliber scientists, learning a great deal from them. I am thrilled to be joining a forward-thinking company and look forward to putting this knowledge and my experience in the pharma industry to good use in my challenging new role. It’s a very exciting time,” said Lydia of her appointment.